Growing Manufacturing Capabilities InterHealth has recently invested in a manufacturing facility and acquired two ingredient companies, indicating an expansion in production capacity and scope. This presents opportunities to collaborate with the company on custom ingredient development or supply chain expansion for new or existing products.

Strong Brand Portfolio The company owns a range of well-backed proprietary brands such as UC-II, Super CitriMax, and ZMA, supported by clinical data, making them a trusted supplier for dietary supplement and functional food manufacturers seeking proven ingredients.

Partnership and Acquisition History Having been acquired by Kainos Capital and later by Lonza Group, InterHealth demonstrates a history of strategic partnerships and investments that could open doors for joint ventures, licensing deals, or supply agreements with potential partners or clients within the nutraceutical industry.

Niche Market Focus Specializing in branded nutritional ingredients for dietary supplements, functional foods, beverages, and cosmetics, InterHealth targets a broad yet specific segment that presents numerous sales opportunities with companies expanding product lines or seeking research-backed ingredients.

Technological and R&D Capabilities Utilizing advanced tech stack and a strong focus on clinical data, InterHealth is positioned to meet the needs of manufacturers requiring high-quality, science-supported ingredients, making it an attractive partner for innovative companies looking to differentiate their offerings.